Impact of theophylline/corticosteroid combination therapy on sputum hydrogen sulfide levels in patients with COPD
Paul A. Kirkham, Matthew Whiteman, Paul G. Winyard, Gaetano Caramori, Fabiana Gordon, Paul A. Ford, Peter J. Barnes, Ian M. Adcock, Kian Fan Chung
European Respiratory Journal 2014; DOI: 10.1183/09031936.00131513
Paul A. Kirkham
1Airways Diseases, National Heart and Lung Institute, Imperial College London, London,
2Dept of Biomedical Sciences, University of Wolverhampton, Wolverhampton,
Matthew Whiteman
3University of Exeter Medical School, Exeter,
Paul G. Winyard
3University of Exeter Medical School, Exeter,
Gaetano Caramori
4Dipartimento di Scienze Mediche, Centro Interdipartimentale per lo Studio delle Malattie Infiammatorie delle Vie Aeree e Patologie Fumo-correlate (CEMICEF), Sezione di Medicina Interna e Cardiorespiratoria, Università di Ferrara, Ferrara, Italy
Fabiana Gordon
5Statistical Advisory Service, Imperial College London, London, UK
Paul A. Ford
1Airways Diseases, National Heart and Lung Institute, Imperial College London, London,
Peter J. Barnes
1Airways Diseases, National Heart and Lung Institute, Imperial College London, London,
Ian M. Adcock
1Airways Diseases, National Heart and Lung Institute, Imperial College London, London,
Kian Fan Chung
1Airways Diseases, National Heart and Lung Institute, Imperial College London, London,
Abstract
COPD patients with low airway H2S benefit from theophylline/corticosteroid therapy with increased FEV1 and H2S levels http://ow.ly/sx2u4
- Received July 30, 2013.
- Accepted January 4, 2014.
- © ERS
Vol 63 Issue 4
Table of Contents
Impact of theophylline/corticosteroid combination therapy on sputum hydrogen sulfide levels in patients with COPD
Paul A. Kirkham, Matthew Whiteman, Paul G. Winyard, Gaetano Caramori, Fabiana Gordon, Paul A. Ford, Peter J. Barnes, Ian M. Adcock, Kian Fan Chung
European Respiratory Journal Jan 2014, erj01315-2013; DOI: 10.1183/09031936.00131513
Impact of theophylline/corticosteroid combination therapy on sputum hydrogen sulfide levels in patients with COPD
Paul A. Kirkham, Matthew Whiteman, Paul G. Winyard, Gaetano Caramori, Fabiana Gordon, Paul A. Ford, Peter J. Barnes, Ian M. Adcock, Kian Fan Chung
European Respiratory Journal Jan 2014, erj01315-2013; DOI: 10.1183/09031936.00131513